Exquiron Biotech Company

Exquiron is dedicated to contract research in early stage drug discovery. Exquiron Biotech is dedicated to state-of-the-art hit identification and validation services for its customers. With a combined team track record of over 60 years in early stage drug discovery and a high level of expertise and flexibility, they help their customers advance their programs and generate added value in the areas of pharmaceutical drug discovery and nutraceuticals.
Technology: Precision Medicine
Industry: P3 Medicine
Headquarters: Reinach, Aargau, Switzerland
Founded Date: 2013
Employees Number: 11-50
Funding Status: M&A

Visit Website
Register and Claim Ownership